Geode Capital Management
BTTX

Geode Capital Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Geode Capital Management’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-168,821
Closed -$32.9K – 4664
2023
Q4 		$32.9K Buy
168,821
+61,943
+58% +$13.5K ﹤0.01% 4440
2023
Q3 		$41.2K Sell
106,878
-14,846
-12% -$10K ﹤0.01% 4462
2023
Q2 		$131K Buy
121,724
+64,615
+113% +$62.5K ﹤0.01% 4224
2023
Q1 		$41.6K Hold
57,109
– – ﹤0.01% 4559
2022
Q4 		$63K Sell
57,109
-135
-0.2% -$199 ﹤0.01% 4533
2022
Q3 		$100K Buy
57,244
+19,300
+51% +$35.2K ﹤0.01% 4580
2022
Q2 		$59K Buy
37,944
+3,097
+9% +$5.18K ﹤0.01% 4741
2022
Q1 		$68K Buy
+34,847
New +$120K ﹤0.01% 4750

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return